Toxic Encephalopathy and Methemoglobinemia after 5-Amino-2-(trifluoromethyl)pyridine Poisoning

Int J Environ Res Public Health. 2022 Oct 28;19(21):14031. doi: 10.3390/ijerph192114031.

Abstract

The aromatic amino compound 5-amino-2-(trifluoromethyl)pyridine acts as an intermediate in the synthesis of pharmaceutical products. However, the toxicity profile of this compound is sparse and no related poisoning events have been reported. Here, we report the case of a 35-year-old man who inhaled 5-amino-2-(trifluoromethyl)pyridine at work. After inhalation, the patient rapidly developed symptoms such as dizziness, fatigue, nausea, vomiting, chest tightness, and loss of consciousness. After admission, methemoglobinemia, hemolytic anemia, acute renal failure, and toxic encephalopathy occurred. Symptoms improved significantly after intravenous treatment with a low dose of methylene blue. This revealed that 5-amino-2-(trifluoromethyl)pyridine is toxic to the human body and can be absorbed through the respiratory tract, resulting in methemoglobinemia and toxic encephalopathy; thus, caution should be taken in industrial production.

Keywords: 5-amino-2-(trifluoromethyl)pyridine; acute renal failure; magnetic resonance imaging; methemoglobinemia; toxic encephalopathy.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anemia, Hemolytic* / drug therapy
  • Humans
  • Male
  • Methemoglobinemia* / chemically induced
  • Methemoglobinemia* / drug therapy
  • Methylene Blue
  • Neurotoxicity Syndromes*
  • Poisoning*
  • Pyridines / therapeutic use
  • Pyridines / toxicity

Substances

  • Methylene Blue
  • Pyridines

Grants and funding

This study was supported by the Beijing medical and health foundation (Grant no. YWJKJJHKYJJ-BXS5-22001) and the Chen Xiao-ping Foundation for the Development of Science and Technology of Hubei Province (Grant no. CXPJJH12000005-07-40).